ImmunityBio
Commercializes ANKTIVA while developing cytokine, NK-cell, and vaccine immunotherapies for cancer.
$8.07
After-hours close+0.02 (+0.25%)
At close$8.05(−4.17%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 19.86%208.02M sharesInsiders 27.18%284.68M sharesOther 52.96%554.65M shares
Shares outstanding 1.05B · Float 113.84M · 10.9% free float
Institutions13F, as of Jun 30, 2026
437 holders · 208.02M shares · 67 new positions · 206 increased · 107 reduced · 50 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 34.08M | 3.25% | +7.74M | Aug 7, 2026 |
| State Street Corp | 21.40M | 2.04% | +3.69M | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 17.86M | 1.71% | +1.54M | Aug 13, 2026 |
| Vanguard Capital Management LLC | 15.69M | 1.50% | +563.9K | Aug 13, 2026 |
| D. E. Shaw & Co., Inc. | 11.55M | 1.10% | −1.02M | Aug 14, 2026 |
| Two Sigma Investments, LP | 11.10M | 1.06% | +6.71M | Aug 14, 2026 |
| Geode Capital Management, LLC | 9.85M | 0.94% | +1.82M | Aug 12, 2026 |
| Millennium Management LLC | 5.58M | 0.53% | +4.16M | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Patrick Soon-Shiongincl. Cambridge Equities, LP, MP 13 Ventures, LLC +3 more | 64.80% | 745.52M | 13D | Aug 6, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Patrick Soon-Shiong | director, 10 percent owner, officer: See remarks | 280.78M | 26.81% | Apr 2, 2026 |
| Barry J. Simon | director | 2.80M | 0.27% | Jun 26, 2026 |
| Richard Adcock | director, officer: CEO & President | 560.3K | 0.05% | Feb 24, 2026 |
| David C. Sachs | officer: Chief Financial Officer | 300.1K | 0.03% | Feb 24, 2026 |
| Cheryl Cohen | director | 125.4K | 0.01% | Jul 6, 2026 |
| Regan J. Lauer | officer: Chief Accounting Officer | 115.9K | 0.01% | Feb 24, 2026 |
1 ten-percent owner holds 13.9K shares by Form 4, outside the officers-and-directors figure above · 12 people have not refiled in the last 18 months (1.70M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 1, 2026 | Christobel Seleckydirector | Sale | 159,478 | $9.02 | 0 |
| Jul 2, 2026 | Cheryl Cohendirector | Sale | 131,210 | $9.50 | 125,386 |
| Jun 29, 2026 | Christobel Seleckydirector | Sale | 95,722 | $9.01 | 0 |
| Jun 30, 2026 | Christobel Seleckydirector | Sale | 1,000 | $9.00 | 0 |
| Jun 24, 2026 | Barry J. Simondirector | Sale | 25,000 | $7.88 | 2,802,788 |
| Jun 4, 2026 | Barry J. Simondirector | Sale | 23,033 | $7.18 | 2,827,788 |
| Feb 24, 2026 | Barry J. Simondirector | Sale | 75,000 | $12.01 | 2,850,821 |
| Feb 23, 2026 | Barry J. Simondirector | Sale | 165,000 | $10.25 | 2,925,821 |
| Feb 20, 2026 | Barry J. Simondirector | Sale | 10,000 | $9.25 | 3,081,604 |
| Feb 23, 2026 | Christobel Seleckydirector | Sale | 25,000 | $10.00 | 0 |
CongressHouse and Senate disclosures
Not reported.